Reactivation of latent and disseminated cytomegalovirus in a returning traveller with ulcerative colitis.

Olivia Lucey, Iain Carroll, Thomas Bjorn, Michael Millar
Author Information
  1. Olivia Lucey: The Royal London Hospital, Whitechapel Road, Whitechapel, London E1 1BB, UK.
  2. Iain Carroll: The Royal London Hospital, Whitechapel Road, Whitechapel, London E1 1BB, UK.
  3. Thomas Bjorn: The Royal London Hospital, Whitechapel Road, Whitechapel, London E1 1BB, UK.
  4. Michael Millar: The Royal London Hospital, Whitechapel Road, Whitechapel, London E1 1BB, UK.

Abstract

INTRODUCTION: We describe a case of progressive disseminated histoplasmosis (PDH) and disseminated cytomegalovirus (CMV) with development of haemophagocytic lymphohistiocytosis in a 62-year-old man of Bangladeshi origin living in the UK.
CASE PRESENTATION: The patient had a background of ulcerative colitis for which he took prednisolone and azathioprine. He presented with fever, lethargy, cough, weight loss and skin redness, and was initially treated for bacterial cellulitis and investigated for underlying malignancy. He developed multiple progressive erythematous skin lesions, sepsis and colitis requiring management on intensive care. A skin biopsy showed yeasts in the dermis and sub-cutaneous fat, which were confirmed as by PCR. Disseminated CMV with evidence of end organ gastrointestinal disease was also diagnosed. Despite anti-viral and anti-fungal treatment, the patient deteriorated with evidence of bone marrow suppression and a diagnosis of haemophagocytic lymphohistiocytosis was made.
CONCLUSION: PDH is classically seen in patients with significant immunosuppression, e.g. those with human immunodeficiency virus (HIV) or on anti-TNF therapy; however, we present a case of reactivation of in a non-HIV patient. We consider the importance of contemplating reactivation of endemic mycoses and CMV in critically unwell and deteriorating patients.

Keywords

References

  1. J Infect Dis. 2002 Feb 1;185(3):273-82 [PMID: 11807708]
  2. Chest. 2005 Jan;127(1):233-41 [PMID: 15653989]
  3. Gastroenterology. 2008 Apr;134(4):929-36 [PMID: 18294633]
  4. JAMA. 2008 Jul 23;300(4):413-22 [PMID: 18647984]
  5. Med Mycol. 2008 Nov;46(7):725-8 [PMID: 18671166]
  6. Braz J Microbiol. 2006 Jan;37(1):1-13 [PMID: 20445761]
  7. Br J Anaesth. 2012 Feb;108(2):229-35 [PMID: 22157846]
  8. Am J Trop Med Hyg. 2014 Jun;90(6):982-983 [PMID: 24778192]
  9. Curr Trop Med Rep. 2014 Mar 28;1:119-128 [PMID: 24860719]
  10. Eur J Clin Microbiol Infect Dis. 2017 Jun;36(6):993-997 [PMID: 28161744]

Word Cloud

Created with Highcharts 10.0.0disseminatedprogressivecytomegalovirusCMVhaemophagocyticlymphohistiocytosispatientcolitisskinreactivationcasehistoplasmosisPDHulcerativeevidencepatientsimmunosuppressionINTRODUCTION:describedevelopment62-year-oldmanBangladeshioriginlivingUKCASEPRESENTATION:backgroundtookprednisoloneazathioprinepresentedfeverlethargycoughweightlossrednessinitiallytreatedbacterialcellulitisinvestigatedunderlyingmalignancydevelopedmultipleerythematouslesionssepsisrequiringmanagementintensivecarebiopsyshowedyeastsdermissub-cutaneousfatconfirmedPCRDisseminatedendorgangastrointestinaldiseasealsodiagnosedDespiteanti-viralanti-fungaltreatmentdeterioratedbonemarrowsuppressiondiagnosismadeCONCLUSION:classicallyseensignificanteghumanimmunodeficiencyvirusHIVanti-TNFtherapyhoweverpresentnon-HIVconsiderimportancecontemplatingendemicmycosescriticallyunwelldeterioratingReactivationlatentreturningtravellerliposomalamphotericinB

Similar Articles

Cited By